Improving Pediatric Clostridioides difficile Testing Practices: Implementation of a 2-Tier Diagnostic Pathway: Pediatric Clostridioides difficile Testing pathway

sarah Sylvester; Charalene Fisher; Abdallah Dalabih; Elizabeth Marrero; Lydia Sietsema; Michele D Honeycutt; Bobby L Boyanton; Esma Birisci; Brittany Slagle

doi:10.58877/japaj.v1i3.77

Authors

sarah Sylvester University of Arkansas for Medical Sciences
Charalene Fisher University of Arkansas for Medical Sciences
Abdallah Dalabih UAMS
Elizabeth Marrero Arkansas Children’s Hospital
Lydia Sietsema Arkansas Children’s Northwest
Michele D Honeycutt Arkansas Children’s Hospital
Bobby L Boyanton University of Arkansas for Medical Sciences
Esma Birisci Uludag University
Brittany Slagle University of Arkansas for Medical Sciences

DOI:

https://doi.org/10.58877/japaj.v1i3.77

Keywords:

Clostridioides difficile, Clinical Pathway, Pediatrics, polymerase chain reaction

Abstract

Introduction: Clostridioides difficile (C. difficile) is a significant concern for children, especially for those who are hospitalized or who have underlying medical conditions. Diagnosis of C. difficile infection (CDI) in these patients can be challenging due to asymptomatic colonization. Inappropriate testing and non-adherence to laboratory testing guidelines can result in increased false-positive rates precipitating unnecessary isolation precautions and antibiotic treatment for these patients.

Methods: This retrospective cohort study aimed to evaluate the effectiveness of a new diagnostic pathway for C. difficile testing that was implemented in two pediatric hospitals. The study design collected data for two years, one year before and one year after pathway implementation. The study highlighted the importance of appropriate testing and the need for interventions to improve testing practices in pediatric patients. A 2-tier testing algorithm was implemented, consisting of polymerase chain reaction (PCR) for the presence or absence of the toxin B gene and an enzyme immunoassay for toxin A/B production. The best practice advisory was used to determine when C. difficile testing should not be performed. The chi-square test and Fisher's Exact Test analyzed the data using SPSS version 29.

Results: The study found a significant association between the implementation of the C. difficile testing pathway and the test positivity rates for both inpatient and emergency department (ED) patients at both hospitals. Out of 159,434 Hospital A inpatients, 71 had positive C. difficile test results, and out of 11,109 Hospital B inpatients, nine had positive test results. Similarly, out of 121,951 Hospital A ED patients, eight had positive test results, and out of 67,999 Hospital B ED patients, 16 had positive test results. The study found a statistically significant association between the pre and post pathway implementation years for both hospitals (p<0.001 for Hospital B inpatient and ED, p=0.033 for Hospital A inpatient, and p=0.004 for Hospital A ED).

Conclusion: Adherence to laboratory testing guidelines, appropriate testing based on factors such as the patient's age, underlying health conditions, recent antibiotic use, and the presence of other infections or illnesses can reduce unnecessary testing and false-positive rates. False-positive results can occur in pediatric patients due to the high rate of asymptomatic colonization, making it essential to use a combination of clinical symptoms, history, and appropriate diagnostic testing to minimize the risk of misdiagnosis.

References

Borali, E., & De Giacomo, C. (2016). Clostridium Difficile Infection in Children: A Review. Journal of pediatric gastroenterology and nutrition, 63(6), e130–e140. https://doi.org/10.1097/MPG.0000000000001264 DOI: https://doi.org/10.1097/MPG.0000000000001264

Khalaf, N., Crews, J. D., DuPont, H. L., & Koo, H. L. (2012). Clostridium difficile: an emerging pathogen in children. Discovery medicine, 14(75), 105–113.

Jain, R., Jones, K., Marsh, D., Raines, S., Calvin, T., Caler, J., Sahu, N., Omar, M., Anderson, J., Dick, J., & Ayaz, S. (2019). Implementation of a Checklist to Reduce False-Positive Testing in Hospital-Acquired Clostridium Difficile Infection. South Dakota medicine : the journal of the South Dakota State Medical Association, 72(8), 368–371.

Geisler, B. P., Jilg, N., Patton, R. G., & Pietzsch, J. B. (2019). Model to evaluate the impact of hospital-based interventions targeting false-positive blood cultures on economic and clinical outcomes. The Journal of hospital infection, 102(4), 438–444. https://doi.org/10.1016/j.jhin.2019.03.012 DOI: https://doi.org/10.1016/j.jhin.2019.03.012

Christensen, A. B., Barr, V. O., Martin, D. W., Anderson, M. M., Gibson, A. K., Hoff, B. M., Sutton, S. H., et al. (2019). Diagnostic stewardship of C. difficile testing: a quasi-experimental antimicrobial stewardship study. Infection control and hospital epidemiology, 40(3), 269–275. https://doi.org/10.1017/ice.2018.336 DOI: https://doi.org/10.1017/ice.2018.336

McDonald, L. C., Gerding, D. N., Johnson, S., Bakken, J. S., Carroll, K. C., Coffin, S. et al. (2018). Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 66(7), e1–e48. https://doi.org/10.1093/cid/cix1085 DOI: https://doi.org/10.1093/cid/cix1085

Pituch, H., Obuch-Woszczatyński, P., Lachowicz, D., Kuthan, R., Dzierżanowska-Fangrat, K., Mikucka, A., Jermakow, K., Pituch-Zdanowska, A., Davies, K., & Polish EUCLID C. difficile Study Group (2018). Prevalence of Clostridium difficile infection in hospitalized patients with diarrhoea: Results of a Polish multicenter, prospective, biannual point-prevalence study. Advances in medical sciences, 63(2), 290–295. https://doi.org/10.1016/j.advms.2018.03.003 DOI: https://doi.org/10.1016/j.advms.2018.03.003

Davies, K., Davis, G., Barbut, F., Eckert, C., Petrosillo, N., & Wilcox, M. H. (2016). Variability in testing policies and impact on reported Clostridium difficile infection rates: results from the pilot Longitudinal European Clostridium difficile Infection Diagnosis surveillance study (LuCID). European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 35(12), 1949–1956. https://doi.org/10.1007/s10096-016-2746-1 DOI: https://doi.org/10.1007/s10096-016-2746-1

Mori, N., Yoshizawa, S., Saga, T., Ishii, Y., Murakami, H., Iwata, M., Collins, D. A., Riley, T. V., & Tateda, K. (2015). Incorrect diagnosis of Clostridium difficile infection in a university hospital in Japan. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 21(10), 718–722. https://doi.org/10.1016/j.jiac.2015.06.009 DOI: https://doi.org/10.1016/j.jiac.2015.06.009

Carroll KC, Mizusawa M. Laboratory Tests for the Diagnosis of Clostridium difficile. Clin Colon Rectal Surg. 2020 Mar;33(2):73-81. doi: 10.1055/s-0039-3400476. Epub 2020 Feb 25. PMID: 32104159; PMCID: PMC7042017.